Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory ascending-dose study of remimazolam intravenous sedation in healthy Japanese men
jRCTs031220009Completed
- Sponsor
- Japan Society for the Promotion of Science
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of remimazolam (12 arms), sponsored by Japan Society for the Promotion of Science. Primary endpoint: Change in sedation depth over time. Started May 2022; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on jRCTs031220009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220009.